BIOREDIS: an integrated platform for end-to-end design of nucleic acid therapeutics.

BIOREDIS is a web-based platform that delivers end-to-end design of next-generation DNA or RNA therapeutics, generating synthesis-ready constructs with competitive coding and RNAi prediction.

• Why it matters: Current tools cover only parts of the nucleic-acid therapeutic workflow and seldom output designs directly usable for synthesis or preclinical testing, limiting precise tissue- and cell-specific targeting.
• What they did: BIOREDIS integrates curated data from nine major biological resources and adds modules for coding sequence optimization, shRNA/siRNA design, promoter/UTR selection, and automated vector construction for AAV, lentiviral, non-viral, and mRNA vaccine formats.
• The result: It supports human, mouse, and rat designs, shows competitive performance in coding sequence optimization and RNAi prediction, and uniquely provides a target-to-construct workflow ready for experimental validation.

AI summary of the abstract · may contain errors · not medical advice · read the paper.